These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. O'Brien WA; Hartigan PM; Daar ES; Simberkoff MS; Hamilton JD Ann Intern Med; 1997 Jun; 126(12):939-45. PubMed ID: 9182470 [TBL] [Abstract][Full Text] [Related]
4. Perspective: human immunodeficiency virus type 1 (HIV-1) RNA end points in HIV clinical trials: issues in interim monitoring and early stopping. Zackin R; Marschner I; Andersen J; Cowles MK; De Gruttola V; Hammer S; Fischl M; Cotton D J Infect Dis; 1998 Mar; 177(3):761-5. PubMed ID: 9498459 [TBL] [Abstract][Full Text] [Related]
5. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings. Chang LW; Harris J; Humphreys E Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictive value of intermittent viremia with combination hiv therapy. Havlir DV; Bassett R; Levitan D; Gilbert P; Tebas P; Collier AC; Hirsch MS; Ignacio C; Condra J; Günthard HF; Richman DD; Wong JK JAMA; 2001 Jul; 286(2):171-9. PubMed ID: 11448280 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS. Coombs RW Clin Lab Med; 1994 Jun; 14(2):301-11. PubMed ID: 7924193 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of drug resistance in human immunodeficiency virus. Richman DD Clin Infect Dis; 1995 Oct; 21 Suppl 2():S166-9. PubMed ID: 8845446 [TBL] [Abstract][Full Text] [Related]
9. Clinical trials and viral load: statement for FDA community meeting May 16. Food and Drug Administration. James JS AIDS Treat News; 1997 May; (No 271):1-4. PubMed ID: 11364367 [TBL] [Abstract][Full Text] [Related]
10. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144 [TBL] [Abstract][Full Text] [Related]
11. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Lucas GM; Chaisson RE; Moore RD Ann Intern Med; 1999 Jul; 131(2):81-7. PubMed ID: 10419445 [TBL] [Abstract][Full Text] [Related]
12. The relationship between virologic and immunologic responses in AIDS clinical research using mixed-effects varying-coefficient models with measurement error. Liang H; Wu H; Carroll RJ Biostatistics; 2003 Apr; 4(2):297-312. PubMed ID: 12925523 [TBL] [Abstract][Full Text] [Related]
13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
14. Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial. Martinez-Picado J; Negredo E; Ruiz L; Shintani A; Fumaz CR; Zala C; Domingo P; Vilaró J; Llibre JM; Viciana P; Hertogs K; Boucher C; D'Aquila RT; Clotet B; Ann Intern Med; 2003 Jul; 139(2):81-9. PubMed ID: 12859157 [TBL] [Abstract][Full Text] [Related]
16. Future implications: compliance and failure with antiretroviral treatment. Patel AK; Patel KK J Postgrad Med; 2006; 52(3):197-200. PubMed ID: 16855321 [TBL] [Abstract][Full Text] [Related]
17. Long-term immunologic and virologic responses in patients with highly resistant HIV infection who are treated with an incompletely suppressive antiretroviral regimen. Gandhi T; Nagappan V; Cinti S; Wei W; Kazanjian P Clin Infect Dis; 2007 Oct; 45(8):1085-92. PubMed ID: 17879930 [TBL] [Abstract][Full Text] [Related]
18. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK; Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573 [TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS; Dokubo EK; Sint TT Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370 [TBL] [Abstract][Full Text] [Related]
20. Modeling the short-, middle- and long-term viral load responses for comparing estimated dynamic parameters. Huang Y Biom J; 2007 Jun; 49(3):429-40. PubMed ID: 17623347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]